Cisbio pro-collagen type 1 (HUMAN) kits and alpha-SMA assay kits
Ended Purchase Order Awarded
- Contract number
- 75N95019P00132
- Awardee
-
Cisbio US, Inc. UEI D3QENK4DJ9M4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $79,534
Award facts
- Opportunity
-
- Cisbio Pro-Collagen Type 1 (Human) Kits and Alpha-SMA Assay Kits, brand name or equal Pre-Solicitation · 75N95019Q00029 · Posted Dec 7, 2018
- Cisbio Pro-collagen Type 1 (human) and Alpha-SMA kits assay kits, brand name or equal Solicitation · Posted Dec 31, 2018
- Contract value 100% obligated
- $79,533.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the purchase of Cisbio Pro-Collagen Type 1 (Human) Kits and Alpha-SMA Assay Kits by the National Center for Advancing Translational Sciences (NCATS), a center within the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services (HHS). The $79,533.50 firm-fixed-price purchase order was awarded to Cisbio US, Inc., a foreign-owned for-profit company, and was not set aside for any small business category. The kits are being procured to support a TRND Relaxin FIU project at NCATS focused on measuring type 1 collagen as a marker for inflammation. The original pre-solicitation indicated a requirement for 12 assay kits total - 6 Pro-Collagen Type 1 (Human) kits and 6 Alpha-SMA kits.
Quick answers
Who was awarded contract 75N95019P00132?
75N95019P00132 was awarded to Cisbio US, Inc. by National Institute on Drug Abuse (National Institutes of Health) on January 25, 2019.
How much is contract 75N95019P00132 worth?
The government has obligated $79,534 on 75N95019P00132.
Which agency awarded contract 75N95019P00132?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019P00132, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95019P00132 competed?
The extent of competition for 75N95019P00132 was competed under sap. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award